Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Alkylating
  • Bone Neoplasms
  • Dioxoles
  • Isoquinolines
  • Osteosarcoma
  • Salvage Therapy

abstract

  • ET-743 was found to be well tolerated in heavily pretreated osteosarcoma patients but had limited antitumor activity as a single agent. The combination of ET-743 with cisplatin or doxorubicin should be considered.

publication date

  • August 15, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.11563

PubMed ID

  • 12910529

Additional Document Info

start page

  • 832

end page

  • 40

volume

  • 98

number

  • 4